Close Menu
Nabka News
  • Home
  • News
  • Business
  • China
  • India
  • Pakistan
  • Political
  • Tech
  • Trend
  • USA
  • Sports

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

OpenAI plans ChatGPT changes after suicides, lawsuit

August 27, 2025

Floral displays adorn Beijing ahead of V-Day parade-Xinhua

August 26, 2025

Over 190,000 relocated across Punjab as Sutlej swells: NDMA

August 26, 2025
Facebook X (Twitter) Instagram
  • Home
  • About NabkaNews
  • Advertise with NabkaNews
  • DMCA Policy
  • Privacy Policy
  • Terms of Use
  • Contact us
Facebook X (Twitter) Instagram Pinterest Vimeo
Nabka News
  • Home
  • News
  • Business
  • China
  • India
  • Pakistan
  • Political
  • Tech
  • Trend
  • USA
  • Sports
Nabka News
Home » Former X CEO Linda Yaccarino takes helm at digital health company eMed
Tech

Former X CEO Linda Yaccarino takes helm at digital health company eMed

i2wtcBy i2wtcAugust 5, 2025No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp Copy Link
Follow Us
Google News Flipboard Threads
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link


Linda Yaccarino, CEO of X Corp., attends the Milken Institute Global Conference 2025 in Beverly Hills, California, U.S., May 5, 2025.

Mike Blake | Reuters

Linda Yaccarino, the former chief executive of Elon Musk’s social media platform X, is pivoting into health care.

The digital health company eMed Population Health on Tuesday announced it has appointed Yaccarino as its new CEO. EMed is developing a population health management platform for the blockbuster weight loss and diabetes drugs called GLP-1s, the company said. It had raised a total $22 million as of 2022, according to PitchBook.

Yaccarino, who rose rose to the top of NBCUniversal’s global advertising business before joining X, will help eMed establish “game-changing partnerships” and navigate complex markets, the company said.

“The healthcare industry has been disrupted by technology, but not yet completely transformed by it,” Yaccarino said in a statement. “There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before.”

EMed is part of the growing group of digital health companies that are trying to capitalize on the sky-high demand for GLP-1s. Goldman Sachs analysts expect 15 million U.S. adults to be on anti-obesity drugs by 2030, and they predict the industry could reach $100 billion in annual revenue by that time.

Yaccarino stepped down from her role as CEO at X in July and did not disclose a reason for her departure. EMed said she is a “highly sought-after leader” with an “undeniable ability to negotiate new partnerships.”

“To be a leader in today’s healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,” Yaccarino said.

WATCH: Linda Yaccarino steps down as CEO of Elon Musk’s X after two years in the role

Linda Yaccarino steps down as CEO of Elon Musk’s X after two years in the role



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp Copy Link
i2wtc
  • Website

Related Posts

Tech

OpenAI plans ChatGPT changes after suicides, lawsuit

August 27, 2025
Tech

Okta Q2 earnings report 2026

August 26, 2025
Tech

EchoStar stock surges 75% on $23 billion AT&T wireless spectrum deal

August 26, 2025
Tech

Meta used National PTA to push child safety efforts: report

August 26, 2025
Tech

Google says YouTube TV to lose Fox channels if new deal isn’t reached

August 25, 2025
Tech

Intel says Trump deal has risks for shareholders, international sales

August 25, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

OpenAI plans ChatGPT changes after suicides, lawsuit

August 27, 2025

House Republicans unveil aid bill for Israel, Ukraine ahead of weekend House vote

April 17, 2024

Prime Minister Johnson presses forward with Ukraine aid bill despite pressure from hardliners

April 17, 2024

Justin Verlander makes season debut against Nationals

April 17, 2024
Don't Miss

Trump says China’s Xi ‘hard to make a deal with’ amid trade dispute | Donald Trump News

By i2wtcJune 4, 20250

Growing strains in US-China relations over implementation of agreement to roll back tariffs and trade…

Donald Trump’s 50% steel and aluminium tariffs take effect | Business and Economy News

June 4, 2025

The Take: Why is Trump cracking down on Chinese students? | Education News

June 4, 2025

Chinese couple charged with smuggling toxic fungus into US | Science and Technology News

June 4, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

About Us
About Us

Welcome to NabkaNews, your go-to source for the latest updates and insights on technology, business, and news from around the world, with a focus on the USA, Pakistan, and India.

At NabkaNews, we understand the importance of staying informed in today’s fast-paced world. Our mission is to provide you with accurate, relevant, and engaging content that keeps you up-to-date with the latest developments in technology, business trends, and news events.

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

OpenAI plans ChatGPT changes after suicides, lawsuit

August 27, 2025

Floral displays adorn Beijing ahead of V-Day parade-Xinhua

August 26, 2025

Over 190,000 relocated across Punjab as Sutlej swells: NDMA

August 26, 2025
Most Popular

China launches test satellite into ultra-low orbit (video)

May 23, 2024

Zhongnanhai: The scenic garden that became China’s secretive seat of power

May 25, 2024

Keep an eye on China profit trends and keep an eye on the yen

May 26, 2024
© 2025 nabkanews. Designed by nabkanews.
  • Home
  • About NabkaNews
  • Advertise with NabkaNews
  • DMCA Policy
  • Privacy Policy
  • Terms of Use
  • Contact us

Type above and press Enter to search. Press Esc to cancel.